Mostrar el registro sencillo del ítem
dc.contributor.author
Baena, Armando
dc.contributor.author
Paolino, Melisa Delia
dc.contributor.author
Villarreal Garza, Cynthia
dc.contributor.author
Torres, Gabriela
dc.contributor.author
Delgado, Lucia
dc.contributor.author
Ruiz, Rossana
dc.contributor.author
Canelo Aybar, Carlos
dc.contributor.author
Song, Yang
dc.contributor.author
Feliu, Ariadna
dc.contributor.author
Maza, Mauricio
dc.contributor.author
Jeronimo, Jose
dc.contributor.author
Espina, Carolina
dc.contributor.author
Almonte, Maribel
dc.date.available
2024-06-10T10:31:51Z
dc.date.issued
2023-10
dc.identifier.citation
Baena, Armando; Paolino, Melisa Delia; Villarreal Garza, Cynthia; Torres, Gabriela; Delgado, Lucia; et al.; Latin America and the Caribbean Code Against Cancer 1st Edition: Medical interventions including hormone replacement therapy and cancer screening; Elsevier; Cancer Epidemiology; 86; 10-2023; 1-13
dc.identifier.issn
1877-7821
dc.identifier.uri
http://hdl.handle.net/11336/237560
dc.description.abstract
Prostate, breast, colorectal, cervical, and lung cancers are the leading cause of cancer in Latin America and the Caribbean (LAC) accounting for nearly 50% of cancer cases and cancer deaths in the region. Following the IARC Code Against Cancer methodology, a group of Latin American experts evaluated the evidence on several medical interventions to reduce cancer incidence and mortality considering the cancer burden in the region. A recommendation to limit the use of HRT was issued based on the risk associated to develop breast, endometrial, and ovarian cancer and on growing concerns related to the over-the-counter and without prescription sales, which in turn bias estimations on current use in LAC. In alignment with WHO breast and cervical cancer initiatives, biennial screening by clinical breast examination (performed by trained health professionals) from the age of 40 years and biennial screening by mammography from the age of 50 years to 74, as well as cervical screening by HPV testing (either self-sampling or provider-sampling) every 5–10 years for women aged 30–64 years, were recommended. The steadily increasing rates of colorectal cancer in LAC also led to recommend colorectal screening by occult blood testing every two years or by endoscopic examination of the colorectum every 10 years for both men and women aged 50–74 years. After evaluating the evidence, the experts decided not to issue recommendations for prostate and lung cancer screening; while there was insufficient evidence on prostate cancer mortality reduction by prostate-specific antigen (PSA) testing, there was evidence of mortality reduction by low-dose computed tomography (LDCT) targeting high-risk individuals (mainly heavy and/or long-term smokers) but not individuals with average risk to whom recommendations of this Code are directed. Finally, the group of experts adapted the gathered evidence to develop a competency-based online microlearning program for building cancer prevention capacity of primary care health professionals.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Elsevier
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by/2.5/ar/
dc.subject
Cancer prevention
dc.subject
Hormone replacement therapy use
dc.subject
Cancer screening and early diagnosis
dc.subject
Latin America and the Caribbean Code Against Cance
dc.subject.classification
Epidemiología
dc.subject.classification
Ciencias de la Salud
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Latin America and the Caribbean Code Against Cancer 1st Edition: Medical interventions including hormone replacement therapy and cancer screening
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2024-06-07T15:21:24Z
dc.journal.volume
86
dc.journal.pagination
1-13
dc.journal.pais
Países Bajos
dc.journal.ciudad
Amsterdam
dc.description.fil
Fil: Baena, Armando. Agencia Internacional de Investigación En Cáncer; Francia
dc.description.fil
Fil: Paolino, Melisa Delia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro de Estudios de Estado y Sociedad; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
dc.description.fil
Fil: Villarreal Garza, Cynthia. Hospital Zambrano Hellion; México
dc.description.fil
Fil: Torres, Gabriela. Instituto Nacional de Salud Pública; México
dc.description.fil
Fil: Delgado, Lucia. Universidad de la República; Uruguay
dc.description.fil
Fil: Ruiz, Rossana. Instituto Nacional de Enfermedades Neoplasicas; Perú
dc.description.fil
Fil: Canelo Aybar, Carlos. Biomedical Research Institute Sant Pau; España
dc.description.fil
Fil: Song, Yang. Biomedical Research Institute Sant Pau; España
dc.description.fil
Fil: Feliu, Ariadna. International Agency for Research on Cancer; Francia
dc.description.fil
Fil: Maza, Mauricio. Pan American Health Organization; Estados Unidos
dc.description.fil
Fil: Jeronimo, Jose. National Institutes of Health; Estados Unidos
dc.description.fil
Fil: Espina, Carolina. International Agency for Research on Cancer; Francia
dc.description.fil
Fil: Almonte, Maribel. International Agency for Research on Cancer; Francia
dc.journal.title
Cancer Epidemiology
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.canep.2023.102446
Archivos asociados